Form CORRESP - Correspondence:
SEC Accession No. 0001193125-15-027640
Filing Date
2015-01-30
Accepted
2015-01-30 15:45:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 41562
  Complete submission text file 0001193125-15-027640.txt   42484
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations